Non-alcoholic Fatty Liver Diseases (NAFLD) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Effect of a Food Supplementation With a Combined Food Supplement on Lipid Pattern, Indexes of Non-alcoholic Fatty Liver Disease and Systemic Inflammation
Conditions: Hypercholesterolemia Interventions: Dietary Supplement: Dietary Supplement; Other: Placebo Sponsors: University of Bologna Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials

Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors
Conditions: Non-alcoholic Fatty Liver Disease; Liver Fibrosis; Liver Injury Interventions: Drug: Ganwei; Drug: Metformin; Drug: Placebo Sponsors: Taipei City Hospital; The One Biopharmaceutical Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials

Direct Versus Indirect Effect of Amino Acids on Hepatokines
Conditions: Non-Alcoholic Fatty Liver Disease; Obesity Interventions: Other: Evaluating the acute effect of an amino acid infusion with and without a concomitant infusion of the somatostatin analogue octreotide to eliminate endogenous production of glucagon Sponsors: University of Copenhagen; Bispebjerg Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials

Can Fecal Calprotectin Be Used as a Biomarker in Obese Adolescents?
Conditions: Obesity, Childhood; NAFLD Interventions: Diagnostic Test: Fecal Calprotectin Test Sponsors: Sisli Hamidiye Etfal Training and Research Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Non-Alcoholic Fatty Liver Disease (PARADISE-NAFLD)
Conditions: Non-alcoholic Fatty Liver Disease Interventions: Device: focused power ultrasound mediated inferior perirenal adipose tissue modification; Device: sham-control group Sponsors: The First Affiliated Hospital with Nanjing Medical University; The Affiliated Jiangning Hospital of Nanjing Medical University; Suzhou Municipal Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials

A Nutrigenetic Intervention in MASLD
Conditions: NAFLD; Fatty Liver Interventions: Behavioral: Dietary intervention Sponsors: Maastricht University; Istanbul University - Cerrahpasa (IUC) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials

Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease
Conditions: Type 2 Diabetes; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Henagliflozin; Other: Background medication Sponsors: Sir Run Run Shaw Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials

Non-Invasive Diagnostic Tests for MASLD in Pediatric Population
Conditions: Metabolic Dysfunction Associated Steatotic Liver Disease; Non-Alcoholic Fatty Liver Disease (NAFLD) Interventions: Diagnostic Test: Velacur; Diagnostic Test: MRI; Diagnostic Test: Blood sample collection for biomarkers; Diagnostic Test: Liver biopsy Sponsors: Emory University; Sonic Incytes Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials

Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study
Conditions: Cardiovascular Diseases; Metabolic Syndrome; Non-Alcoholic Fatty Liver Disease Interventions: Behavioral: Digital wearable and AI-human symbiotic lifestyle intervention Sponsors: National University Hospital, Singapore; National University of Singapore Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials

Liver Steatosis in Pediatric CD Patients
Conditions: Celiac Disease in Children; Non-Alcoholic Fatty Liver Disease Interventions: Behavioral: Gluten-free diet Sponsors: University of Palermo; ARNAS Civico Di Cristina Benfratelli Hospital; Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials

Effects of Two Different Exercise Programs and Diet in Obese Subjects With NAFLD
Conditions: Obesity; NAFLD Interventions: Behavioral: Aerobic Exercise and diet intervention; Behavioral: Hiit and diet intervention; Behavioral: Diet Sponsors: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis; Antonella Bianco; Isabella Franco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 1, 2024 Category: Research Source Type: clinical trials

Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease; Non Alcoholic Fatty Liver; Non Alcoholic Steatohepatitis; NAFLD; NASH Interventions: Drug: Hyperpolarized (HP) 13C; Drug: Hyperpolarized 13C-Urea; Procedure: Magnetic Resonance Imaging; Procedure: Saline Flush Sponsors: Michael Ohliger, MD PhD; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials

The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind Trial
Conditions: Non-alcoholic Fatty Liver Disease Interventions: Other: Ginseng oligopeptide (Ginseng extract ）; Other: Maltodextrin Sponsors: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials

Elucidating Growth Hormone Dynamics at Stages of Progressive Nonalcoholic Fatty Liver Disease
Conditions: Nonalcoholic Fatty Liver Disease Sponsors: Massachusetts General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Conditions: NASH/MASH; NAFLD/MASLD Interventions: Drug: Efruxifermin; Drug: Placebo Sponsors: Akero Therapeutics, Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials